Artelo Biosciences reported cash from operations of -$2.91M and free cash flow of -$2.91M for the quarter ended Dec 2025, down 13.4% year over year. This cash flow statement covers 47 quarters of results from May 2014 through Dec 2025, standardized by Business Quant from the company’s SEC filings.
| Cash Flow Statement | May2014 | Aug2014 | Nov2014 | Feb2015 | May2015 | Aug2015 | Nov2015 | Feb2016 | May2016 | Aug2016 | Nov2016 | Feb2017 | May2017 | Aug2017 | Nov2017 | Feb2018 | May2018 | Aug2018 | Nov2018 | Feb2019 | May2019 | Aug2019 | Nov2019 | Feb2020 | May2020 | Aug2020 | Nov2020 | Feb2021 | May2021 | Aug2021 | Nov2021 | Mar2022 | Jun2022 | Sep2022 | Dec2022 | Mar2023 | Jun2023 | Sep2023 | Dec2023 | Mar2024 | Jun2024 | Sep2024 | Dec2024 | Mar2025 | Jun2025 | Sep2025 | Dec2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | |||||||||||||||||||||||||||||||||||||||||||||||
| Net Income | -1.87M | -2.25M | -2.55M | -1.95M | -2.47M | -2.40M | -3.48M | -2.29M | -1.78M | -2.61M | -3.24M | -2.59M | -2.51M | -1.20M | -3.81M | -2.37M | -3.22M | -3.19M | -2.80M | ||||||||||||||||||||||||||||
| Depreciation and DepletionDep. & Depletion | 62.00 | 61.00 | |||||||||||||||||||||||||||||||||||||||||||||
| Share-based CompensationStock Comp. | 0.34M | 0.57M | 0.62M | 0.62M | 0.61M | 0.61M | 0.35M | 0.23M | 0.22M | 0.22M | 0.21M | 0.20M | 0.21M | 0.20M | 0.19M | 0.15M | 0.43M | 0.37M | |||||||||||||||||||||||||||||
| Cash from OperationsCash from Ops. | -0.89M | -1.93M | -2.05M | -1.97M | -1.70M | -2.29M | -2.19M | -1.62M | -1.80M | -2.60M | -2.94M | -2.06M | -0.78M | -2.57M | -1.60M | -0.51M | -3.50M | -2.91M | |||||||||||||||||||||||||||||
| Depreciation, Depletion & Amortization | |||||||||||||||||||||||||||||||||||||||||||||||
| Depreciation & Amortization (CF)Dep. & Amort. | 62.00 | 61.00 | |||||||||||||||||||||||||||||||||||||||||||||
| Change in Working Capital | |||||||||||||||||||||||||||||||||||||||||||||||
| Change in Account PayablesChange Payables | 0.02M | 0.02M | 0.01M | -0.02M | 0.03M | 0.03M | -0.04M | 0.00M | -0.02M | 0.05M | -0.04M | -0.01M | 0.03M | -0.04M | 0.00M | 0.01M | 0.31M | ||||||||||||||||||||||||||||||
| Change in Accured ExpensesChange Accured Exp. | 0.11M | 0.13M | -0.16M | -0.38M | -0.02M | 0.55M | -0.21M | -0.19M | 0.33M | 0.37M | -0.62M | 0.26M | -0.26M | 1.08M | 0.80M | 2.25M | -0.91M | -0.83M | |||||||||||||||||||||||||||||
| Other Working Capital ChangesOther WC Changes | 0.08M | -0.01M | -0.09M | -0.01M | -0.01M | -0.01M | -0.16M | -0.01M | -0.09M | -0.26M | -0.07M | -0.01M | -0.03M | -0.48M | 0.06M | -0.01M | -0.05M | -0.05M | -0.02M | ||||||||||||||||||||||||||||
| Investing Activities | |||||||||||||||||||||||||||||||||||||||||||||||
| Capital ExpendituresCapex | |||||||||||||||||||||||||||||||||||||||||||||||
| Cash from Investing ActivitiesCash from Investing | 8.37M | -8.88M | 0.26M | 3.98M | -3.08M | 1.80M | 2.20M | 0.40M | -1.83M | 2.74M | 1.27M | 1.75M | 4.25M | 0.50M | -0.25M | 0.19M | |||||||||||||||||||||||||||||||
| Financing Activities | |||||||||||||||||||||||||||||||||||||||||||||||
| Cash from Financing ActivitiesCash from Financing | 5.32M | 18.26M | -0.13M | 0.13M | 0.54M | 0.03M | 0.06M | 0.06M | 1.82M | 3.44M | 1.61M | ||||||||||||||||||||||||||||||||||||
| Debt Issuance and Repayment | |||||||||||||||||||||||||||||||||||||||||||||||
| Non-Current Debt | -0.01M | 338.00 | |||||||||||||||||||||||||||||||||||||||||||||
| Change in Capital Stock | |||||||||||||||||||||||||||||||||||||||||||||||
| Net Equity Issued and RepurchasedNet Equity Issued | 1.01M | 18.26M | 0.54M | 0.03M | 0.06M | 0.06M | 1.08M | 3.31M | 1.76M | ||||||||||||||||||||||||||||||||||||||
| Additional items | |||||||||||||||||||||||||||||||||||||||||||||||
| Exchange Rate EffectFX Effect | 0.04M | -0.04M | -0.02M | -0.11M | -0.21M | 0.12M | 0.01M | 0.03M | 0.02M | -0.00M | -0.00M | -0.00M | 0.00M | -0.01M | 0.01M | 0.02M | -0.04M | -0.00M | |||||||||||||||||||||||||||||
| Change in Cash | 3.32M | 7.42M | -1.81M | 1.77M | -4.99M | -0.25M | 0.03M | -1.20M | -3.08M | 0.18M | -1.62M | -0.31M | 3.48M | -2.02M | -1.59M | 1.32M | -0.35M | -1.12M | |||||||||||||||||||||||||||||
| Free Cash FlowFCF | -0.89M | -1.93M | -2.05M | -1.97M | -1.70M | -2.29M | -2.19M | -1.62M | -1.80M | -2.60M | -2.94M | -2.06M | -0.78M | -2.57M | -1.60M | -0.51M | -3.50M | -2.91M | |||||||||||||||||||||||||||||
| Net Cash FlowNCF | 12.79M | 7.46M | -1.80M | 1.89M | -4.78M | -0.36M | 0.01M | -1.22M | -3.10M | 0.18M | -1.62M | -0.31M | 3.47M | -2.01M | -1.60M | 1.30M | -0.30M | -1.12M |
Pull Artelo Biosciences's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/statements?ticker=ARTL&statement=CF&frequency=Quarter&period=all&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/statements"
params = {"ticker": "ARTL", "statement": "CF", "frequency": "Quarter", "period": "all", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/statements?ticker=ARTL&statement=CF&frequency=Quarter&period=all&api_key=YOUR_API_KEY");
const data = await res.json();